
Albert Font
CEO
Leanbio
About me
Leanbio is a cutting-edge CDMO specializing in recombinant proteins, antibodies, bioconjugates, and mRNA. With both microbial and mammalian production platforms, the company deliver seamless, end-to-end biopharmaceutical development and manufacturing services.
The company offers tailored cell line development solutions for a broad range of protein types, from standard monoclonal antibodies to complex and novel biologics.
Social media
Contact details
Is member of
Leanbio
Exhibitorsis attending
Building a Collaborative Supply Chain for Biological Products: A Roadmap for the Future
Tuesday, October 24, 2023 9:40 AM to 10:00 AM
CPHI Content Hub - CC4.3
Biologics Capability and Capacity Expansion Driving Shift to CRDMO Business Models
Tuesday, October 24, 2023 10:05 AM to 10:25 AM
CPHI Content Hub - CC4.3
CDMO 2.0: Uncovering the Missing Element in Next-Generation Pharma Partnerships
Tuesday, October 24, 2023 12:15 PM to 12:35 PM
CPHI Content Hub - CC4.3
Peter Andersen · Grupo Centroflora
Managing Outsourcing Relationships to Optimise Manufacturing Operations
Tuesday, October 24, 2023 1:30 PM to 1:50 PM
CPHI Content Hub - CC4.3
CDMO Selection for the Biotech: A Practical Guide
Tuesday, October 24, 2023 12:40 PM to 1:00 PM
CPHI Content Hub - CC4.3